In March 2020, Valid Insight brought together a panel of global payers and industry representatives to talk about how the COVID-19 pandemic may affect global market access. Now, 6 months on, we review what global changes have occurred, and discuss how these changes may have profound market access implications in the future, along with solutions to future-proof.
Join us and our esteemed speaker panel, consisting of:
- Sue Caleo-Naeyaert: Former Global Head Government Affairs, Policy and Pharmacoeconomics at Fresenius Kabi SwissBioSim
- Prof. Fabrizio Gianfrate: Professor of Health Economics. Former AIFA member and Director of the Ministry of Health
- Leslie Galloway: Expert Adviser at the NICE Centre for Clinical Practice and Chairman of the Ethical Medicines Industry Group (EMIG)
Click here for additional information and registration details.
Related Content
Evidence Matters 2022
Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.
Achieving Consensus When Everyone is an Expert, but No One Agrees
Join experts from PHAR, Novartis, and Bausch Health for a discussion around the Delphi panels and how the results are used.
Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Experts will present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.